Study of RVT-1401 for the Treatment of Patients With Active, Moderate to Severe Graves’ Ophthalmopathy ( GO )

Condition:   Graves’ Ophthalmopathy (GO)
Interventions:   Drug: RVT-1401 (Administered via subcutaneous injection);   Other: Placebo (Administered via subcutaneous injection)
Sponsor:   Immunovant Sciences GmbH
Not yet recruiting
ClinicalTrials.gov: Ophthalmology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days